Log in to save to my catalogue

Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of p...

Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2665562318

Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of prematurity: the importance of retinal vascularization

About this item

Full title

Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of prematurity: the importance of retinal vascularization

Publisher

Dordrecht: Springer Netherlands

Journal title

International ophthalmology, 2022-10, Vol.42 (10), p.3199-3210

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

Purpose
To evaluate the factors that may be associated with refractive outcome in eyes treated with intravitreal bevacizumab (IVB) injection for retinopathy of prematurity (ROP).
Methods
Retrospective case series. Refractive outcomes of 181 infants who were treated with primary IVB for Type I ROP or aggressive ROP, were retrospectively eva...

Alternative Titles

Full title

Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of prematurity: the importance of retinal vascularization

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2665562318

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2665562318

Other Identifiers

ISSN

1573-2630,0165-5701

E-ISSN

1573-2630

DOI

10.1007/s10792-022-02321-6

How to access this item